25 results
8-K
EX-99.1
ADPT
Adaptive Biotechnologies Corp
3 Nov 22
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
4:16pm
growth and innovation across our businesses with a clear path to profitability.”
Recent Highlights
Revenue of $47.8 million for the third quarter
8-K
EX-99.1
mfwwrk0wmryu
17 Mar 21
Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
4:31pm
424B5
vltz2v245v3woi
16 Jul 20
Prospectus supplement for primary offering
4:26pm
424B5
ciqrekhz7g
14 Jul 20
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
v1jepz0 bdd9zt
5 May 20
Regulation FD Disclosure
12:00pm
DEF 14A
ty1x0lxr3kxn1om
24 Apr 20
Definitive proxy
4:15pm
8-K
EX-99.1
klu5uuz3 zynlp4i2lxx
20 Mar 20
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
2:13pm
10-K
nwbc qgn4j2uc
26 Feb 20
Annual report
4:53pm
424B4
g6bt2eo tgxvo5l8ioej
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
pda2y18w66djm8he6zg
9 Jan 20
Draft registration statement
12:00am
424B4
eflv6gm8
27 Jun 19
Prospectus supplement with pricing info
5:24pm